CA2348319C - Derives de cyclohexenol et medicament les contenant - Google Patents

Derives de cyclohexenol et medicament les contenant Download PDF

Info

Publication number
CA2348319C
CA2348319C CA002348319A CA2348319A CA2348319C CA 2348319 C CA2348319 C CA 2348319C CA 002348319 A CA002348319 A CA 002348319A CA 2348319 A CA2348319 A CA 2348319A CA 2348319 C CA2348319 C CA 2348319C
Authority
CA
Canada
Prior art keywords
disease
cyclohexenol
derivative according
cyclohexenol derivative
degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002348319A
Other languages
English (en)
Other versions
CA2348319A1 (fr
Inventor
Bang Luu
Jacquot Delphine
Celine Junges-Girlanda
Jose-Luis Gonzalez De Aguilar
Bernadette Lutz-Bucher
Jean-Philippe Loeffler
Masashi Yamada
Yukie Suma
Hiroto Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Strasbourg
Original Assignee
Meiji Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Milk Products Co Ltd filed Critical Meiji Milk Products Co Ltd
Priority to CA002348319A priority Critical patent/CA2348319C/fr
Publication of CA2348319A1 publication Critical patent/CA2348319A1/fr
Application granted granted Critical
Publication of CA2348319C publication Critical patent/CA2348319C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/02Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
    • C07C35/08Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings
    • C07C35/18Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings with unsaturation at least in the ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002348319A 2001-05-24 2001-05-24 Derives de cyclohexenol et medicament les contenant Expired - Fee Related CA2348319C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002348319A CA2348319C (fr) 2001-05-24 2001-05-24 Derives de cyclohexenol et medicament les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002348319A CA2348319C (fr) 2001-05-24 2001-05-24 Derives de cyclohexenol et medicament les contenant

Publications (2)

Publication Number Publication Date
CA2348319A1 CA2348319A1 (fr) 2002-11-24
CA2348319C true CA2348319C (fr) 2009-09-08

Family

ID=4169089

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002348319A Expired - Fee Related CA2348319C (fr) 2001-05-24 2001-05-24 Derives de cyclohexenol et medicament les contenant

Country Status (1)

Country Link
CA (1) CA2348319C (fr)

Also Published As

Publication number Publication date
CA2348319A1 (fr) 2002-11-24

Similar Documents

Publication Publication Date Title
DE69508463T2 (de) Propiophenonderivate und Verfahren zu deren Herstellung
DE69232630T2 (de) Makrocyclische immunmodulatoren
JPH05213966A (ja) 免疫抑制活性を有するn−ヘテロアリール、n−アルキルヘテロアリール、n−アルケニルヘテロアリールおよびn−アルキニルヘテロアリールマクロライド類
JPS63502593A (ja) マノアリド類似体
NO170280B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
EP1003706A1 (fr) Alcool a chaine longue cyclohexenone et medicament le contenant
CA1336598C (fr) Derives d'oxime d'octahydronaphtalene comme inhibiteurs de la synthese du cholesterol, leur procede de preparation et leur composition
WO2004092100A1 (fr) Derives d'indene utilises en tant qu'agents pharmaceutiques
DE69220639T2 (de) Herstellung und Verwendung von neuen Glykosiden von Catechol-Östrogenen
DE2714129A1 (de) Prostaglandinderivate, verfahren zu deren herstellung und deren verwendung
US6011060A (en) Chiral phenyldihydrofuranones as PDE-IV inhibitors
EP1860103B1 (fr) Compose anticancereux, son intermediaire et procedes de production
CA2348319C (fr) Derives de cyclohexenol et medicament les contenant
US5200536A (en) Fluorine-containing vitamin D3 analogues
JP4354585B2 (ja) シクロヘキセノール誘導体及びこれを含有する医薬
DE69231215T2 (de) Reduktionsprodukte von Rapamycin als immunosuppressive, entzündungshemmende und antifungale Mittel
DE69121000T2 (de) Alpha-Mannosidase- und fucosidase-Hemmer
JPH10502058A (ja) アリール、アルキル、アルケニルおよびアルキニルマクロライド
KR100556335B1 (ko) 6알-(3,6-디데옥시-엘-아라비노-헥소피라노실옥시)헵타노익산, 그 제조방법 및 그를 포함하는 장기휴면 유발효과
JPH0453877B2 (fr)
DE60203937T2 (de) Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivaten
Senuma et al. Highly Effective Resolution of 1, 3-Dibenzyl-6-hydroxy-3, 3a, 6, 6a-tetrahydro-1H-furo [3, 4-d] imidazole-2, 4-dione, an Intermediate for Biotin, with Optically Active Amines and Reutilizatin of the Unwanted Epimer
JPH02292237A (ja) 6―フルオロシキミ酸誘導体、その製造方法、該化合物を含有する細菌及び菌類感染の治療用薬剤学的組成物、該化合物を含有する殺菌類剤及び殺草剤、及び中間体
DE69131522T2 (de) Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel
US4560703A (en) Clavulone derivatives, process for preparing the same, and use of said compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160524